It is still not clear whether jaundice of unknown aetiology, developing during the neonatal period, is of significance for the subsequent development of athetosis and related diseases. In a previous study (Trolle, 1961) , the author calculated that among children who have had neonatal jaundice of unknown aetiology, athetosis of later onset is so uncommon that the decision to perform an exchange transfusion merely on the basis of an arbitrarily selected bilirubin value must be regarded as unjustified. As an example, it was calculated that if routine exchange transfusion were performed on the indication of a bilirubin value of 20 mg./100 ml. and over, a total of 2,140 transfusions would have been performed in mature infants in order to save one from athetosis, while there is a present risk that 21 would have died as a result of the exchange. In the case of prematures, 92 exchange transfusions would have been necessary in order to save one child from athetosis, but with the present risk four would have died as a result of the transfusion. The criterion for exchange transfusion cannot therefore be based only on the serum bilirubin value.
In obstetric departments and children's departments, this question of exchange transfusion in the newborn suffering from jaundice of unknown aetiology is constantly arising. In what follows, therefore, three questions will be discussed. First, since the cause of jaundice in each individual infant appears to be unknown, is it the result of a number of known clinical factors? Second, in how many cases can the jaundice be considered to play a role in the subsequent development of athetosis? Third, why do some jaundiced newborn infants subsequently develop athetosis, while others, equally or more jaundiced, do not?
To elucidate the above topics, the serum bilirubin values have been systematically determined in all clinically jaundiced children born during a two-year period (April 1, 1960 to March 31, 1962) . Since values below 8-9 mg./100 ml. cannot be expected to cause clinical jaundice (Larsen and With, 1943) , information is given only on the incidence of jaundice with serum bilirubin values of 10 mg./ 100 ml. or more. The determinations were made on heel blood taken daily and sometimes several times a day. The micromethod used (Jendrassik and Groof) gives the total bilirubin concentration. The analyses were done at the Central Laboratory of the University Hospital.
In addition, serological examinations were carried out on all jaundiced children and their mothers at the Blood Bank of the University Hospital. Further details are given in an earlier paper (Trolle, 1961) .
The patients admitted to our department are in many ways selected. There is, for instance, a high number of premature births and complicated cases (excluding mothers with diabetes and heart failure).
The jaundice of the newborn occurring in the two-year period was caused either by rhesus incompatibility or by ABO and other blood-group incompatibility, or its aetiology was unknown. No cases of obliteration of the bile-ducts were seen.
During this time there were 3,846 liveborn single births weighing more than 650 g. As a prophylactic measure all the newborn babies were given 2 5 mg. menadione intramuscularly immediately after birth. If antibiotics were needed, prophylactically or therapeutically, penicillin was used, but never sulphur preparations. Children born prematurely were placed in an incubator for a few hours only, but oxygen was given through a funnel for some days.
Of the 3,846 liveborn single births, 300 had haemolytic disease due to rhesus, ABO and/or other blood-group incompatibility. These 300 newborn will not be discussed further. It is worth mentioning that 45% of the newborn babies with jaundice of unknown aetiology belonged to blood group 0, which is the same percentage as found in the whole population of Denmark. In the newborn surviving the first week of life the incidence ofjaundice ofunknown aetiology is 28 3 %. * This big difference in mortality is a consequence of the fact that of the 119 newborn who died during the first week of life, 93, or 78%. died less than 48 hours after birth, and 109, or 92%, died less than 72 hours after birth. At this stage, pronounced jaundice of unknown aetiology is only rarely present. After 72 hours, there were 10 deaths (8% of the 119 deaths) out of the 2,571 non-jaundiced newborn, i.e. 0 4%, and three deaths out of the 975 jaundiced newborn, i.e. 0 3%. In only one out of aUl these neonatal deaths was kernikterus demonstrated at autopsy: this newborn had jaundice of unknown aetiology, and will be discussed later. The cause of the rise in incidence with falling birth weight is probably an enzyme deficiency in the liver cells. The excretion of the indirect bilirubin requires two different enzymes, namely uridinediphosphate-glucuronic acid dehydrogenase and glucuronyl transferase. Both these enzymes are present in the microsomal fraction of the liver and appear late in the foetal development and only in small amounts. After birth the enzymes increase in number and activity (Brown, Zuelzer and Burnett, 1958; Richter, 1961a) .
Whether other clinical factors are of importance in the incidence of jaundice of unknown aetiology is examined in Table 2 . In relation to the total material, there is an apparent variation in the incidence of jaundice for some of the conditions mentioned in column 1 (Table 2) , but the only statistically significant figures are those for newborn babies weighing 2,500 g. or less, of mothers with toxaemia (p < 0 003). However, babies of toxaemic mothers most often weigh less than other babies of the same gestational age, and this may be an explanation, or part of one.
If one compares the incidence of jaundice in boys and girls, the difference is statistically significant for all three weight groups (p <0'00006). Wood, Culley, Waterhouse and Powell (1962) were not able to demonstrate a significant difference.
Early or late clamping of the umbilical cord has no influence on the occurrence of jaundice (investigations by T. Tobiassen, 1962, unpublished) .
There seems to be a slight seasonal fluctuation. It might be possible that the administration of 2 5 mg. menadione to the babies immediately after birth was a cause of the jaundice. Dyggve (1960) showed that if 10 mg. menadione were given to newborn babies, 19-2% reached a serum bilirubin level of more than 20 mg./100 ml., but if 1 mg. K1 vitamin (which is non-toxic) were given, only 12-3 % reached the same level. In the present material only 2-5 mg. menadione was used, and as seen in Table 1 only 9 8 % of the prematures had a serum bilirubin level of 20 mg./100 ml. or more. The administration of menadione, therefore, cannot explain the appearance of jaundice.
In 60-63 % of those jaundiced, mature as well as premature newborn babies, the maximum serum bilirubin value (10, 15 and 20 mg./100 ml. respectively) was reached on the fourth or fifth day of life. If we include the third and sixth day of life we find that in 91-93 % of the cases the maximum serum bilirubin value appears within these four days, still independent of maturity and the level of the serum bilirubin. (A more detailed analysis is shown in Fig. 1 .) The duration of the jaundice, on the other hand, depends on the magnitude of the maximum serum bilirubin. The higher this value, the longer the jaundice persists. FIGuRE. (Crone, 1961) . The bloodbrain barrier is peculiar in that its permeability is different from that of other tissue. We can only guess why the indirect bilirubin, albeit rarely, does pass the blood-brain barrier in newborn babies with jaundice of unknown aetiology. Some authors suppose that the barrier can be passed only in the case of an unfavourable ratio between the indirect bilirubin and the serum proteins. The unfavourable ratio may be caused by low levels of serum proteins or by displacement of the indirect bilirubin from the serum proteins by ketone bodies, unesterified fatty acids and sulphonamides (Day, 1961) . Other authors suppose that the capillary walls are injured either directly by circulating substances or indirectly by primary damage to the glial cells which closely invest the capillaries of the brain. (See also the discussion in A Conference Presented by the American Academy for Cerebral Palsy (1961) and Richter (1961b) .
Since rhesus-sensitized newborn babies easily develop kernikterus if exchange transfusions are withheld, another explanation for the permeability of the blood-brain barrier must exist. Pentschew (1948) thinks that the antibodies damage the barrier, an explanation in line with the results of Skoog's animal experiments with intravasal injection of Forssman-antigen (1939).
If the above-mentioned account of blood-brain barrier behaviour is correct, there is a most important difference between blood-group-sensitized newborn babies with jaundice and babies with jaundice of unknown aetiology. Even before birth the former possess the factor that damages the blood-brain barrier, while only as an exception do the latter acquire a damaging factor during or after birth. But for both groups it is true to say that without serum bilirubinaemia there is no kernikterus.
It has been customary so far to group newborn babies with jaundice of unknown aetiology together with blood-group-sensitized babies, and it is, therefore, understandable that the bilirubinaemia per se is said to be important for the later development of athetosis. But newborn babies with jaundice of unknown aetiology should also be compared with babies without jaundice. The latter may also develop athetosis, and here the aetiology is mainly asphyxia, particularly in combination with difficult delivery and/or attacks of cyanosis and convulsions during the first days of life; in a few cases the aetiology is malformation of the brain, and finally, in some, the aetiology is unknown (Hansen, 1960 (Table 1 and Birth Weight greater than 2,500 g. Using the same argument for the children with a birth weight greater than 2,500 g., the following conclusions may be drawn. Among children with athetosis and a history of jaundice of unknown aetiology during the first week of life, little more than one-half developed athetosis as a consequence of the jaundice.
If this assumption holds, it should be the duty of the clinician to select those jaundiced newborn babies with a blood-brain barrier allowing indirect bilirubin to pass, and to carry out exchange transfusion in them. But we do not know at present how to find these and it is not justifiable to carry out exchange transfusion as a routine in all jaundiced newborn babies exceeding a fixed serum bilirubin value. Attention should undoubtedly be paid in particular to anoxic newborn babies, especially where labour has been difficult and/or they develop attacks with cyanosis and convulsions during the first few days of life, or show signs of kernikterus. The rate at which the serum bilirubin rises may also be of significance. Only one of the total of 975 newborn babies with jaundice of unknown origin showed a bilirubin value above 20 mg./100 ml. during the first 48 hours after birth (weight 1,750 g., prolonged labour, forceps delivery on account of threatening intrauterine foetal death). This baby showed no sign of kernikterus, and an exchange transfusion was performed on the indication of a rapid rise in bilirubin alone. The child was well on discharge from hospital. The other babies undergoing exchange transfusion during the last 18 months showed no sign of kernikterus either (2,750 g., delivered by vacuum extractor because of slight pre-eclampsia in the mother). Exchange transfusion was done when the serum bilirubin rose to 33 2 mg./100 ml. (fifth day), because of the potential danger.
Autopsies Eight newborn babies, three girls and five boys, with a birth weight between 750 and 1,900 g., died in the second week oJ life. The serum bilirubin value did not exceed 24 mg./100 ml. At the autopsies the brain was immediately fixed in formalin and subsequently examined macro-and microscopically. In none was kernikterus suspected clinically, nor was it demonstrated at autopsy.
Finally, the four newborn infants with jaundice of unknown aetiology who died in the first week of life should be mentioned.
(1) Male, weighing 1,900 g., died 45 hours after birth; the maximum serum bilirubin was 11 -5 mg./100 ml.
(2) Male, weighing 1,600 g., died 158 hours after birth; the maximum serum bilirubin was 25 1 mg./100 ml.
(3) Male, weighing 1,200 g., died 115 hours after birth; maximum serum bilirubin 22-6 mg./100 ml.
(4) Female, weighing 1,050 g., died 97 hours after birth; maximum serum bilirubin 25-5 mg./100 ml.
The kernikterus suspected clinically in no. 2 was confirmed at autopsy.
Conclusion
The two-year period of study falls into two sections. During the first six months, exchange transfusions were made if the bilirubin value was greater than 20 mg./100 ml. (Trolle, 1961 Exchange transfusion is thus rarely indicated and this conclusion is in agreement with the author's conclusions (Trolle, 1961) . The calculation made then, however, was based on a serum bilirubin value of 20 mg./100 ml. or more. But it is known also that lower values than this may cause athetosis (Killander, Miiller-Eberhard and Sjolin, 1960) . It would, therefore, be more correct to calculate the necessity of replacement transfusion for all newborn babies with jaundice of unknown origin, i.e. all those with a serum bilirubin value of 10 mg./100 ml. or more. At the same time, however, from the present study we see that in infants with a history of jaundice of unknown aetiology during the first week of life, any athetosis that develops subsequently is due to the jaundice in only two-thirds of the athetosis cases with a birth weight 2,500 g. or less, and in only a little more than one-half of the athetosis cases with a birth weight greater than 2,500 g.
Using Table 1 from Trolle (1961) , Table 1 in the present study and the premises put forward, the following calculation can be made for children of birth weight 2,500 g. or less. The risk of subsequent athetosis in infants with a history ofjaundice of unknown aetiology in the first week of life is 0.12 % of all births of 2,500 g. or less, i.e. I 2 per 1,000 births. Since the frequency of jaundice of unknown origin (serum bilirubin value 10 mg./ 100 ml. or more) is 58.4%, the risk of subsequent athetosis among newborn babies with a history of jaundice of unknown aetiology in the first week of life is 0 221 %, i.e. 2 I per 1,000 cases. However, the athetosis is due to jaundice in only two-thirds of the cases, so that the risk becomes 1 4 per 1,000. In other words, exchange transfusion should be done in 1-2 per 1,000 newborn babies, 2,500 g. or less, with jaundice of unknown aetiology. In the case of newborn babies with birth weight greater than 2,500 g., the corresponding figures are: 0 0028 % of all babies with a birth weight greater than 2,500g., i.e. 0-28 per 10,000 births. Only 24.7% of these births have jaundice of unknown aetiology, so that the risk of subsequent athetosis among newborn babies with a history of jaundice of unknown aetiology is 1* 13 per 10,000. Only in about one-half of the cases, however, is the athetosis due to jaundice. In other words, exchange transfusion should be done in 0-1 per 10,000 newborn babies with jaundice of unknown origin, who have a birth weight greater than 2,500 g. Mores, Fargasova and Minarikova (1959) concluded from their material that prophylactic exchange transfusions were not indicated in newborn babies with hyperbilirubinaemia without isoimmunization. Shiller and Silverman (1961) have followed up a consecutive number of premature babies (2,000 g. and less) with or without jaundice of unknown aetiology. The children were re-examined when 3 years old by paediatricians, neurologists, psychologists, speech and hearing therapists and dental surgeons. The frequency of neurological deficit and mental retardation had no relation to jaundice of unknown aetiology. Bjure, Liden, Reinand and Vestby (1961) concluded from their follow-up study of full-term newborn babies with jaundice of unknown aetiology (bilirubin 18 mg./100 ml. or more) that hyperbilirubinaemia alone did not give rise to any cerebral lesion.
Summary
In a consecutive series of newborn babies surviving the first week of life, the incidence of jaundice of unknown aetiology was found to be 28-3 % (i.e. 971 out of 3,423). The rise in incidence with falling birth weight is shown in Table 1 . The possible influence of a number of factors on the incidence of jaundice was examined (Table 2) , but only toxaemia in mothers giving birth to babies weighing 2,500 g. or less seems to be significant, as it reduces the incidence. The incidence of jaundice was found to be significantly higher in boys than in girls.
Newborn babies with jaundice of unknown aetiology only rarely develop athetosis. The incidence of jaundice is nearly the same in a group of children with athetosis as in Obstetric Department A's material of all newborn babies (Table 3) . For those who develop athetosis, jaundice of unknown aetiology can explain only some, namely, two-thirds of the children with a birth weight of 2,500 g. or less, and a little more than one-half of the children with a birth weight greater than 2,500 g. In the remaining cases, one-third and almost one-half respectively, the aetiology of the athetosis is assumed to be the same as in children with no jaundice.
On the basis of the results presented, it is concluded that in newborn babies with jaundice of unknown origin exchange transfusion will prevent
